You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
漢商集團(600774.SH):擬9億元購買迪康藥業100%股權
格隆匯 07-28 18:20

格隆匯 7 月 28日丨漢商集團(600774.SH)披露重大資產購買預案,此次重大資產重組的交易方案為上市公司及全資子公司漢商大健康擬以支付現金的方式購買藍光發展和藍迪共享合計持有的迪康藥業100%股權。

此次交易前,藍光發展持有迪康藥業約1.1億股股份,佔迪康藥業總股本的91.41%;藍迪共享持有迪康藥業約1031.08萬股股份,佔迪康藥業總股本的8.59%。

此次交易完成後,迪康藥業將成為上市公司的全資子公司,上市公司將直接持有迪康藥業99%的股份,上市公司的全資子公司漢商大健康將持有迪康藥業1%的股份。

經交易雙方友好協商,此次交易標的資產迪康藥業100%股權的交易作價為9億元,最終交易價格以湖北眾聯資產評估有限公司對標的公司以2020年6月30日為評估基準日進行評估的評估結果為基礎協商確定。

此次交易前,上市公司主營業務為零售、會展等,零售主營業態有百貨商嘗購物中心和專業店等。此次交易的標的資產迪康藥業是以製藥為主,集藥品及醫療器械的研發、製造和營銷於一體的高新技術企業。

此次交易完成後,上市公司將在原有商業板塊業務的基礎上,進一步置入優質醫藥製造板塊標的資產,有利於公司以迪康藥業在醫藥製造領域的競爭力為基礎,加快大健康產業板塊的延伸佈局,推進“商業與大健康產業並行”的發展戰略,為公司股東創造新的可持續盈利的增長點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account